Janus nanogels of PEGylated Taxol and PLGA–PEG–PLGA copolymer for cancer therapy†
Jun Wei,Huaimin Wang,Meifeng Zhu,Dan Ding,Dongxia Li,Zhinan Yin,Lianyong Wang,Zhimou Yang
Nanoscale Pub Date : 08/08/2013 00:00:00 , DOI:10.1039/C3NR02937A
Abstract

Nanogels are promising carriers for the delivery of anti-cancer drugs for cancer therapy. We report in this study on a Janus nanogel system formed by mixing a prodrug of Taxol (PEGylated Taxol) and a copolymer of PLGA–PEG–PLGA. The Janus nanogels have good stability over months in aqueous solutions and the freeze-dried powder of nanogels can be re-dispersed instantly in aqueous solutions. The Janus nanogels show an enhanced inhibition effect on tumor growth in a mice breast cancer model probably due to the enhanced uptake of the nano-sized materials by the EPR effect. What is more, the nanogels can also serve as physical carriers to co-deliver other anti-cancer drugs such as doxorubicin to further improve the anti-cancer efficacy. The results obtained from H&E staining and TUNEL assay also support the observation of tumor growth inhibition. These results suggest the potential of this novel delivery system for cancer therapy.

Graphical abstract: Janus nanogels of PEGylated Taxol and PLGA–PEG–PLGA copolymer for cancer therapy